CD8A and neoplasm: Vascular endothelial growth factor (VEGF) impairs tumor-antigen presentation by hindering the maturation of dendritic cells and upregulating the expression of programmed death-ligand 1 (PD-L1) on dendritic cells, thereby suppressing the function of CD8+ T cells (19, 20).